178 related articles for article (PubMed ID: 16278150)
1. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
[TBL] [Abstract][Full Text] [Related]
2. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
[TBL] [Abstract][Full Text] [Related]
3. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
[TBL] [Abstract][Full Text] [Related]
4. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
5. Reactivity to B cell epitopes within hepatitis C virus core protein and hepatocellular carcinoma.
Pirisi M; Fabris C; Toniutto P; Vitulli D; Soardo G; Falleti E; Gonano F; Ferroni P; Gasparini V; Bartoli E
Cancer Res; 1995 Jan; 55(1):111-4. PubMed ID: 7528637
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis.
Elefsiniotis IS; Diamantis ID; Dourakis SP; Kafiri G; Pantazis K; Mavrogiannis C
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):721-6. PubMed ID: 12811301
[TBL] [Abstract][Full Text] [Related]
7. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
10. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
11. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
12. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
Oyunsuren T; Kurbanov F; Tanaka Y; Elkady A; Sanduijav R; Khajidsuren O; Dagvadorj B; Mizokami M
J Med Virol; 2006 Dec; 78(12):1688-95. PubMed ID: 17063518
[TBL] [Abstract][Full Text] [Related]
13. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
14. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
Eto M; Kodama S; Uemura N; Suzuki M
Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541
[TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
18. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
19. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM
Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]